Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fluorescein Angiography | 31 | 2024 | 1051 | 5.200 |
Why?
|
Tomography, Optical Coherence | 50 | 2024 | 2907 | 4.860 |
Why?
|
Visual Acuity | 33 | 2024 | 2662 | 3.620 |
Why?
|
Macular Degeneration | 11 | 2024 | 1005 | 3.110 |
Why?
|
Retinal Vessels | 13 | 2024 | 851 | 2.730 |
Why?
|
Retinal Pigment Epithelium | 9 | 2024 | 303 | 2.660 |
Why?
|
Choroid | 10 | 2024 | 352 | 2.570 |
Why?
|
Macula Lutea | 9 | 2024 | 169 | 2.500 |
Why?
|
Vitelliform Macular Dystrophy | 8 | 2021 | 18 | 2.340 |
Why?
|
Choroideremia | 4 | 2024 | 27 | 2.030 |
Why?
|
Fundus Oculi | 14 | 2024 | 548 | 1.800 |
Why?
|
Choroid Diseases | 3 | 2024 | 63 | 1.610 |
Why?
|
Retinal Diseases | 7 | 2023 | 704 | 1.570 |
Why?
|
Wet Macular Degeneration | 6 | 2024 | 162 | 1.550 |
Why?
|
Fovea Centralis | 5 | 2019 | 126 | 1.240 |
Why?
|
Choroidal Neovascularization | 10 | 2020 | 363 | 1.060 |
Why?
|
Retinal Drusen | 2 | 2024 | 74 | 1.060 |
Why?
|
Retinal Vein Occlusion | 2 | 2023 | 149 | 0.930 |
Why?
|
Retinal Perforations | 2 | 2024 | 138 | 0.870 |
Why?
|
Hemangioma, Capillary | 1 | 2023 | 62 | 0.840 |
Why?
|
Angioid Streaks | 2 | 2019 | 14 | 0.830 |
Why?
|
Bruch Membrane | 2 | 2019 | 65 | 0.820 |
Why?
|
Retinitis Pigmentosa | 3 | 2021 | 397 | 0.820 |
Why?
|
Capillaries | 4 | 2020 | 755 | 0.820 |
Why?
|
Electroretinography | 2 | 2023 | 521 | 0.820 |
Why?
|
Visual Field Tests | 1 | 2024 | 411 | 0.760 |
Why?
|
Retinal Neoplasms | 1 | 2023 | 146 | 0.760 |
Why?
|
Intravitreal Injections | 9 | 2023 | 385 | 0.750 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2023 | 563 | 0.700 |
Why?
|
Retinal Hemorrhage | 1 | 2020 | 95 | 0.680 |
Why?
|
Retinoschisis | 1 | 2019 | 30 | 0.660 |
Why?
|
Cerebellar Ataxia | 1 | 2021 | 150 | 0.660 |
Why?
|
Diabetic Retinopathy | 3 | 2024 | 1275 | 0.650 |
Why?
|
Retinal Ganglion Cells | 2 | 2024 | 810 | 0.630 |
Why?
|
Retina | 9 | 2024 | 2652 | 0.590 |
Why?
|
Eye Abnormalities | 1 | 2018 | 241 | 0.510 |
Why?
|
Cytoskeletal Proteins | 1 | 2021 | 1341 | 0.490 |
Why?
|
Phenotype | 3 | 2023 | 16585 | 0.480 |
Why?
|
Atrophy | 3 | 2024 | 1631 | 0.450 |
Why?
|
Disease Progression | 8 | 2024 | 13484 | 0.450 |
Why?
|
Optic Disk | 1 | 2018 | 421 | 0.450 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2021 | 2895 | 0.430 |
Why?
|
Angiogenesis Inhibitors | 9 | 2023 | 2047 | 0.420 |
Why?
|
Vision Disorders | 1 | 2019 | 1088 | 0.400 |
Why?
|
Contrast Sensitivity | 2 | 2024 | 244 | 0.400 |
Why?
|
Fibrosis | 3 | 2023 | 2048 | 0.380 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2023 | 3486 | 0.350 |
Why?
|
Cross-Sectional Studies | 14 | 2024 | 26063 | 0.340 |
Why?
|
Retinal Dystrophies | 2 | 2022 | 65 | 0.340 |
Why?
|
Genotype | 2 | 2023 | 12976 | 0.340 |
Why?
|
Wound Healing | 1 | 2021 | 2799 | 0.340 |
Why?
|
Ophthalmoscopy | 2 | 2019 | 171 | 0.310 |
Why?
|
Follow-Up Studies | 13 | 2024 | 39078 | 0.280 |
Why?
|
Humans | 56 | 2024 | 760437 | 0.270 |
Why?
|
Middle Aged | 32 | 2024 | 220382 | 0.260 |
Why?
|
Macular Edema | 2 | 2020 | 374 | 0.260 |
Why?
|
Young Adult | 17 | 2024 | 59068 | 0.250 |
Why?
|
Prospective Studies | 17 | 2023 | 54339 | 0.250 |
Why?
|
Male | 38 | 2024 | 360035 | 0.240 |
Why?
|
Aged | 23 | 2024 | 168840 | 0.240 |
Why?
|
Italy | 3 | 2022 | 840 | 0.230 |
Why?
|
Adult | 26 | 2024 | 220781 | 0.220 |
Why?
|
Geographic Atrophy | 1 | 2024 | 83 | 0.220 |
Why?
|
Vision Tests | 1 | 2023 | 161 | 0.210 |
Why?
|
Nerve Fibers | 2 | 2024 | 708 | 0.210 |
Why?
|
Adolescent | 16 | 2024 | 88196 | 0.210 |
Why?
|
Aged, 80 and over | 10 | 2024 | 58859 | 0.210 |
Why?
|
Mutation | 3 | 2023 | 30025 | 0.210 |
Why?
|
Nephritis, Hereditary | 1 | 2022 | 78 | 0.210 |
Why?
|
Female | 35 | 2024 | 391875 | 0.200 |
Why?
|
Pseudoxanthoma Elasticum | 2 | 2018 | 14 | 0.200 |
Why?
|
cis-trans-Isomerases | 1 | 2022 | 44 | 0.200 |
Why?
|
Retrospective Studies | 10 | 2024 | 80430 | 0.170 |
Why?
|
Microvessels | 2 | 2024 | 574 | 0.170 |
Why?
|
Retinal Telangiectasis | 1 | 2019 | 25 | 0.160 |
Why?
|
DNA | 2 | 2023 | 7208 | 0.160 |
Why?
|
Myopia, Degenerative | 1 | 2018 | 15 | 0.160 |
Why?
|
Rubella Syndrome, Congenital | 1 | 2018 | 12 | 0.150 |
Why?
|
Quarantine | 1 | 2020 | 181 | 0.150 |
Why?
|
Child, Preschool | 7 | 2023 | 42209 | 0.150 |
Why?
|
Retinal Neurons | 1 | 2018 | 66 | 0.150 |
Why?
|
Fluorescein | 1 | 2018 | 174 | 0.150 |
Why?
|
Vitreous Body | 1 | 2019 | 399 | 0.150 |
Why?
|
Eye Infections, Viral | 1 | 2018 | 60 | 0.140 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2019 | 251 | 0.140 |
Why?
|
Child | 11 | 2023 | 80086 | 0.140 |
Why?
|
Incidence | 3 | 2023 | 21322 | 0.120 |
Why?
|
Visual Fields | 1 | 2022 | 1055 | 0.120 |
Why?
|
Capillary Permeability | 1 | 2018 | 773 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1790 | 0.110 |
Why?
|
Ophthalmology | 1 | 2020 | 550 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2022 | 1371 | 0.100 |
Why?
|
Disease Management | 1 | 2021 | 2501 | 0.090 |
Why?
|
Calcinosis | 1 | 2018 | 1469 | 0.080 |
Why?
|
Microscopy, Acoustic | 2 | 2018 | 47 | 0.080 |
Why?
|
Indocyanine Green | 2 | 2020 | 233 | 0.070 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2023 | 664 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12054 | 0.070 |
Why?
|
Coloring Agents | 2 | 2020 | 559 | 0.070 |
Why?
|
Time Factors | 4 | 2021 | 39947 | 0.070 |
Why?
|
Aging | 1 | 2024 | 8689 | 0.060 |
Why?
|
Lutein | 1 | 2024 | 122 | 0.060 |
Why?
|
Retinal Neovascularization | 1 | 2024 | 288 | 0.050 |
Why?
|
Ciliary Arteries | 1 | 2020 | 19 | 0.050 |
Why?
|
Infant | 1 | 2022 | 36183 | 0.040 |
Why?
|
Cohort Studies | 1 | 2023 | 41366 | 0.040 |
Why?
|
Blood-Retinal Barrier | 1 | 2019 | 62 | 0.040 |
Why?
|
Subretinal Fluid | 1 | 2018 | 24 | 0.040 |
Why?
|
Hydroxychloroquine | 1 | 2022 | 426 | 0.040 |
Why?
|
Reference Values | 1 | 2024 | 4921 | 0.030 |
Why?
|
Basement Membrane | 1 | 2017 | 348 | 0.030 |
Why?
|
Risk Factors | 1 | 2023 | 74055 | 0.030 |
Why?
|
Angiography | 1 | 2019 | 1599 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2022 | 4108 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2023 | 2642 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2022 | 2723 | 0.030 |
Why?
|
Observer Variation | 1 | 2018 | 2604 | 0.020 |
Why?
|
Photochemotherapy | 1 | 2018 | 823 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3734 | 0.020 |
Why?
|
Databases, Factual | 1 | 2024 | 7948 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14565 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7230 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8611 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20078 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12969 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22097 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29551 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64591 | 0.010 |
Why?
|
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_